Baltimore, MD, United States of America

Katharine M Wright

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Johns Hopkins University. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Katharine M Wright. Retrieved from https://idiyas.com/inventor/katharine-m-wright

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 11.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Katharine M. Wright: Innovator in Tumor Antigen Targeting

Introduction

Katharine M. Wright is a prominent inventor based in Baltimore, MD (US). She has made significant contributions to the field of cancer research, particularly in the area of tumor antigen targeting. Her innovative work has the potential to advance therapeutic strategies for cancer treatment.

Latest Patents

Katharine holds a patent for her invention titled "MANAbodies Targeting Tumor Antigens and Methods of Using." This patent represents her commitment to developing novel approaches in the fight against cancer. She has been recognized for her unique contributions to medical science.

Career Highlights

Katharine is affiliated with Johns Hopkins University, where she continues her research and development efforts. Her work at this prestigious institution has allowed her to collaborate with leading experts in the field, further enhancing her impact on cancer research.

Collaborations

Some of her notable coworkers include Sandra B. Gabelli and Bert Vogelstein. Their collaborative efforts have contributed to advancing the understanding of tumor biology and improving treatment options for patients.

Conclusion

Katharine M. Wright is a trailblazer in the field of tumor antigen targeting, with a patent that showcases her innovative spirit. Her work at Johns Hopkins University and collaborations with esteemed colleagues highlight her dedication to improving cancer therapies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…